| 2026-09-03 | Press release | FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis |
| 2026-09-03 | Press release | FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis |
| 2026-09-03 | 8-K | Form 8-K, Item 8.01 |
| 2026-09-02 | Press release | Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress |
| 2026-08-12 | Deck | Second Quarter 2026 Earnings & Corporate Update |
| 2026-08-12 | Press release | Press release · Q2 2026 · Aug 2026 |
| 2026-08-12 | Press release | Liquidia Corporation Reports Second Quarter 2026 Financial Results |
| 2026-08-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-12 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-12 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-29 | Press release | Press release · Jul 2026 |
| 2026-07-29 | Press release | Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026 |
| 2026-06-18 | Transcript | FY26 earnings call transcript |
| 2026-06-17 | 8-K | Form 8-K, Item 5.07 |
| 2026-06-11 | Press release | Press release · Jun 2026 |
| 2026-06-11 | Press release | Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions |
| 2026-06-08 | Press release | Press release · Jun 2026 |
| 2026-06-08 | Press release | Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index |
| 2026-06-08 | 8-K | Form 8-K, Item 8.01 |
| 2026-05-27 | Press release | Press release · May 2026 |
| 2026-05-27 | Press release | Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference |
| 2026-05-11 | Deck | First Quarter 2026 Earnings & Corporate Update |
| 2026-05-11 | Press release | Press release · Q1 2026 · May 2026 |
| 2026-05-11 | Press release | Liquidia Corporation Reports First Quarter 2026 Financial Results |
| 2026-05-11 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-11 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-06 | Press release | Liquidia Corporation to Participate in Upcoming Investor Conferences |
| 2026-05-04 | Press release | Press release · Q1 2026 · May 2026 |
| 2026-05-04 | Press release | Liquidia Corporation to Report First Quarter 2026 Financial Results on |
| 2026-04-24 | Proxy | Definitive proxy statement |
| 2026-04-07 | Press release | Press release · Apr 2026 |
| 2026-04-07 | Press release | Liquidia Corporation to Participate in Upcoming Investor Conferences |
| 2026-03-06 | Transcript | Q4 FY25 earnings call transcript |
| 2026-03-05 | Deck | Investor presentation · FY 2025 · Mar 2026 |
| 2026-03-05 | Press release | Press release · FY 2025 · Mar 2026 |
| 2026-03-05 | Press release | Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
| 2026-03-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-05 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-26 | Press release | Press release · FY 2025 · Feb 2026 |
| 2026-02-26 | Press release | Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026 |